Cognex (NASDAQ:CGNX) Earns "Hold (C)" Rating from Weiss Ratings

Key Points

• Cognex has been reaffirmed a "hold (c)" rating by Weiss Ratings, indicating stable analyst sentiment regarding the stock.
• The stock currently has a consensus rating of "Moderate Buy" with an average target price of $44.93, while several analysts have varied price targets ranging from $32.00 to $55.00.
• Cognex reported a 4.2% year-over-year revenue increase for Q2 2025, posting earnings of $0.25 per share which exceeded estimates, demonstrating positive financial performance.

Cognex (NASDAQ:CGNX - Get Free Report)'s stock had its "hold (c)" rating reaffirmed by investment analysts at Weiss Ratings in a research note issued on Wednesday,Weiss Ratings reports.

A number of other research analysts have also recently weighed in on CGNX. Barclays set a $55.00 price objective on shares of Cognex and gave the company an "overweight" rating in a report on Tuesday. JPMorgan Chase & Co. began coverage on shares of Cognex in a research note on Monday, September 15th. They issued a "neutral" rating and a $45.00 price target for the company. The Goldman Sachs Group boosted their price objective on shares of Cognex from $36.00 to $40.00 and gave the stock a "sell" rating in a research report on Tuesday, September 16th. Robert W. Baird upped their price target on shares of Cognex from $30.00 to $32.00 and gave the company a "neutral" rating in a research report on Monday, June 16th. Finally, Truist Financial set a $45.00 price target on shares of Cognex and gave the company a "hold" rating in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $44.93.

Cognex Trading Up 1.7%

CGNX traded up $0.80 during midday trading on Wednesday, hitting $46.75. 1,320,802 shares of the company traded hands, compared to its average volume of 1,887,327. The company has a market capitalization of $7.85 billion, a price-to-earnings ratio of 65.85 and a beta of 1.50. Cognex has a 52-week low of $22.67 and a 52-week high of $47.52. The business has a 50 day simple moving average of $44.08 and a two-hundred day simple moving average of $34.73.

Cognex (NASDAQ:CGNX - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.02. The business had revenue of $249.09 million for the quarter, compared to the consensus estimate of $246.70 million. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The company's revenue was up 4.2% compared to the same quarter last year. During the same period last year, the firm posted $0.23 earnings per share. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. Equities research analysts anticipate that Cognex will post 0.61 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Sheila Marie Dipalma sold 2,000 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $45.03, for a total value of $90,060.00. Following the sale, the executive vice president directly owned 6,582 shares of the company's stock, valued at approximately $296,387.46. This represents a 23.30% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.60% of the company's stock.

Institutional Trading of Cognex

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. 1620 Investment Advisors Inc. raised its stake in Cognex by 44.2% during the third quarter. 1620 Investment Advisors Inc. now owns 3,564 shares of the scientific and technical instruments company's stock worth $161,000 after purchasing an additional 1,093 shares during the period. Aaron Wealth Advisors LLC purchased a new position in Cognex in the third quarter valued at approximately $1,102,000. GAMMA Investing LLC raised its holdings in Cognex by 10.5% in the third quarter. GAMMA Investing LLC now owns 3,837 shares of the scientific and technical instruments company's stock valued at $174,000 after buying an additional 366 shares during the period. Praxis Investment Management Inc. purchased a new position in Cognex in the third quarter valued at approximately $217,000. Finally, Corient Private Wealth LLC raised its holdings in Cognex by 12.3% in the second quarter. Corient Private Wealth LLC now owns 18,369 shares of the scientific and technical instruments company's stock valued at $583,000 after buying an additional 2,008 shares during the period. Hedge funds and other institutional investors own 88.12% of the company's stock.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.